Bipolar Disorders in Saudi Arabia: What Do We Know So Far?

被引：0

作者：

Almadani, Ahmad H. ^{[1
,2
]}

Alhadi, Ahmad N. ^{[1
,2
,3
]}

Aldawood, Buthainah D. ^{[4
]}

Aleissa, Mariam M. ^{[5
,6
]}

Alosaimi, Fahad D. ^{[1
,2
]}

机构：

[1] King Saud Univ, Coll Med, Dept Psychiat, Riyadh, Saudi Arabia

[2] King Saud Univ, King Saud Univ Med City, Dept Psychiat, Riyadh, Saudi Arabia

[3] King Saud Univ, Coll Med, SABIC Psychol Hlth Res & Applicat Chair, Riyadh, Saudi Arabia

[4] Princess Nourah bint Abdulrahman Univ, Coll Hlth & Rehabil Sci, Dept Clin Psychol, Riyadh, Saudi Arabia

[5] Publ Hlth Lab, Dept Mol Genet, Publ Hlth Author, Riyadh, Saudi Arabia

[6] Alfaisal Univ, Med Sch, Riyadh, Saudi Arabia

来源：

SAUDI JOURNAL OF MEDICINE & MEDICAL SCIENCES | 2025年 / 13卷 / 01期

关键词：

Bipolar disorders; clinical manifestations; epidemiology; etiology; psychotropic medications; Saudi Arabia; OUTPATIENT PSYCHIATRIC SETTINGS; PREVALENCE; PATTERNS; INPATIENT; DIAGNOSES; STIGMA;

D O I：

10.4103/sjmms.sjmms_306_24

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Bipolar disorders (BP) are prevalent neuropsychiatric illnesses affecting 1%-5% of the global population and about 3% of the Saudi population. They are associated with significant comorbidities and negative consequences. Despite being common mental health conditions in Saudi Arabia, stigma persists, with weak character, supernatural beliefs, and weak faith considered as causes. In addition, Saudi patients with BP have been reported to seek help from non-psychiatric healthcare professionals and faith healers. More data are required on BP from Saudi Arabia, including the genetic aspects and their treatment approaches. This narrative review paper explores the epidemiology and clinical manifestations, etiology and biological mechanisms, public knowledge and awareness of the illnesses, and treatment of BP in Saudi Arabia.

引用

页码：1 / 6

页数：6

共 50 条

[41] Prognosis of sickle cell disease in Africa: What do we know and what can we do?
Ranque, Brigitte
BULLETIN DE L ACADEMIE NATIONALE DE MEDECINE, 2024, 208 (05): : 660 - 670
[42] Physicians' Knowledge and Awareness about Biosimilars in Saudi Arabia: What is Imperative to Know ??
Almalki, Ziyad Saeed
Iqbal, Muhammad Shahid
Alossaimi, Manal Abdullah
Lasaf, Alwaleed Mohammed
Almawash, Bandar Abdullah
Aldossary, Fayez Hamoud
Marghalani, Aliyah Mohammed
Alsubaihi, Yazeed Abdulaziz
JOURNAL OF YOUNG PHARMACISTS, 2020, 12 (03) : 280 - 284
[43] Coronavirus variants are spreading in India — what scientists know so far
Gayathri Vaidyanathan
Nature, 2021, 593 : 321 - 322
[44] How long is COVID infectious? What scientists know so far
David Adam
Nature, 2022, 608 : 16 - 17
[45] HOW LONG IS COVID INFECTIOUS? WHAT SCIENTISTS KNOW SO FAR
Adam, David
NATURE, 2022, 608 (7921) : 16 - 17
[46] Interstitial lung abnormalities: What do we know and how do we manage?
Liu, Qi
Zhang, Hai
Han, Baohui
Jiang, Handong
Chung, Kian Fan
Li, Feng
EXPERT REVIEW OF RESPIRATORY MEDICINE, 2021, 15 (12) : 1551 - 1561
[47] What we do not know about ADHD ... yet
Kiely, Bridget
Adesman, Andrew
CURRENT OPINION IN PEDIATRICS, 2015, 27 (03) : 395 - 404
[48] Legionella and legionnaires' disease: What do we know?
Che, D.
Campese, C.
Jarraud, S.
PATHOLOGIE BIOLOGIE, 2011, 59 (03): : 134 - 136
[49] Atrial Failure: What Do We Know About It?
Purwowiyoto, Sidhi Laksono
Setianto, Budhi
Surya, Steven Philip
ACTA MEDICA INDONESIANA, 2022, 54 (01) : 131 - 137
[50] Napping and Obesity in Adults - What do we Know?
Wannamethee, Sasiwarang Goya
CURRENT DIABETES REPORTS, 2024, 24 (11) : 237 - 243

← 1 2 3 4 5 →